Paz Fernandez-Ortega

Dr. Paz Fernandez-Ortega

Institut Català d'Oncologia, Barcelona, Catalonia, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
AMAlex Molassiotis
Alex Molassiotis
PFPaz Fernandez-Ortega
Paz Fernandez-Ortega
DPD. Pud
D. Pud
GOG. Ozden
G. Ozden
JSJ. A. Scott
J. A. Scott
EPE. Patiraki
E. Patiraki
Background: The aim of this study was to explore the use of complementary and alternative medicine (CAM) in cancer patients across a number of European countries. Methods: A descriptive survey design was developed. Fourteen countries participated in the study and data was collected through a descriptive questionnaire from 956 patients. Results: Data suggest that CAM is popular among cancer patients with 35.9% using some form of CAM (range among countries 14.8% to 73.1%). A heterogeneous group of 58 therapies were identified as being used. Herbal medicines and remedies were the most commonly used CAM therapies, together with homeopathy, vitamins/minerals, medicinal teas, spiritual therapies and relaxation techniques. Herbal medicine use tripled from use before diagnosis to use since diagnosis with cancer. Multivariate analysis suggested that the profile of the CAM user was that of younger people, female and with higher educational level. The source of information was mainly from friends/family and the media, while physicians and nurses played a small part in providing CAM-related information. The majority used CAM to increase the body's ability to fight cancer or improve physical and emotional well-being, and many seemed to have benefited from using CAM (even though the benefits were not necessarily related to the initial reason for using CAM). Some 4.4% of patients, however, reported side-effects, mostly transient. Conclusions: It is imperative that health professionals explore the use of CAM with their cancer patients, educate them about potentially beneficial therapies in light of the limited available evidence of effectiveness, and work towards an integrated model of health-care provision.

13 March 2019 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
DHDavid Hui
David Hui
CPCarlos Eduardo Paiva
Carlos Eduardo Paiva
EFEgidio G. Del Fabbro
Egidio G. Del Fabbro
CSChristopher Steer
Christopher Steer
JNJane Naberhuis
Jane Naberhuis
MMMasanori Mori
Masanori Mori

6 September 2005 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
AMAlex Molassiotis
Alex Molassiotis
JSJulia A. Scott
Julia A. Scott
NKNora Kearney
Nora Kearney
DPDorit Pud
Dorit Pud
MMMiriam Magri
Miriam Magri
EPElisabeth Patiraki
Elisabeth Patiraki

31 March 2012 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
PFPaz Fernandez-Ortega
Paz Fernandez-Ortega
MCM. T. Caloto
M. T. Caloto
ECE. Chirveches
E. Chirveches
RMR. Marquilles
R. Marquilles
JFJ. San Francisco
J. San Francisco
ALANTONIO LLOMBART-CUSSAC
ANTONIO LLOMBART-CUSSAC

1 December 2019 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
EAEsther Arimon-Pagès
Esther Arimon-Pagès
JTJoan Torres-Puig-Gros
Joan Torres-Puig-Gros
PFPaz Fernandez-Ortega
Paz Fernandez-Ortega
JCJaume Canela-Soler
Jaume Canela-Soler

24 July 2004 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
AGAgnes Glaus
Agnes Glaus
CKCornelia Knipping
Cornelia Knipping
RMRudolf Morant
Rudolf Morant
BLBurkhard Lebert
Burkhard Lebert
FBFrank Beldermann
Frank Beldermann
AHAndré Hüsler
André Hüsler